Introduction
Mizuguchi et al. first described acute necrotizing encephalopathy (ANE) in 1995; it is characterized by altered mental status, seizures, and coma preceded by a viral upper respiratory tract infection, with multiple, symmetrical brain lesions involving the thalamus, brainstem, tegmentum, and cerebral white matter. 1 Influenza infection is the most common preceding event of ANE. 2 Here, we present a pediatric patient who developed ANE after a respiratory tract infection caused by human bocavirus (HBoV).
Case report
An otherwise healthy 3-year-old girl presented to our hospital with fever, altered mental status and rightsided focal seizure activity. She had a five-day history of fever with rhinorrhea and cough and the more recent development of lethargy, nausea, vomiting and ataxia. There was no past medical history of neurological problems such as seizure activity or an immunodeficiency condition. On physical examination, the patient was unconscious and undergoing a right focal convulsion. The muscle tone was increased and more prominent on the right side. She had nuchal rigidity and positive Kernig's and Brudzinski's signs. Muscle strength and the deep tendon reflexes were normal. She had no papillary edema. The serum sodium, glucose, hepatic enzymes, complete blood count, procalcitonin level, and C-reactive protein were normal. The cerebrospinal fluid (CSF) analysis showed slightly increased protein (48 mg/l) and normal glucose (61 mg/l) levels, without pleocytosis. Gram staining and cultures of the CSF, blood, and urine were negative. The serum ammonium level and other metabolic tests were normal. Electroencephalography (EEG) showed intermittent, isolated spikes with slow wave discharge with underlying activity in the left hemisphere. Antiepileptic therapy was given. Contrast-enhanced cranial magnetic resonance imaging (MRI) showed heterogeneous involvement of the bilateral caudate nuclei and putamen, which was more prominent on the left side (Figures 1-3 ). Based on these findings, ANE was diagnosed. Follow-up MRI on day 14 showed progression of the basal ganglion lesions. Real-time polymerase chain reaction (PCR) analysis of a nasopharyngeal aspirate was positive for HBoV and negative for influenza. Intravenous immunoglobulin was started at a dose of 0.4 g/kg for five days. Baclofen and L-DOPA were prescribed for one month because the patient had a hand tremor and marked rigidity. The patient was referred to physical therapy. At the end of three months, the patient was awake, reactive, and could talk spontaneously and play with her friends. She had no difficulty feeding. Follow-up MRI obtained at six months showed near-complete resolution of the lesions.
Discussion
Here, we described a possible association between HBoV and ANE in a pediatric patient. Mizuguchi et al. proposed the following diagnostic criteria for ANE: (a) acute encephalopathy following a viral febrile disease with rapid deterioration in consciousness or convulsions; (b) increased protein in the CSF without CSF pleocytosis; (c) neuroimaging findings of multiple, symmetric brain lesions involving the bilateral thalami, brainstem, periventricular white matter, internal capsule, putamen, and cerebellum; (d) elevated serum aminotransferases to varying degrees, but no hyperammonemia, and hypoglycemia; and (e) the exclusion of similar diseases. 1 Our case met these criteria, with the exception of elevated serum aminotransferases. Multiple, symmetrical brain lesions in both thalami are the most prominent feature of ANE. In our patient, there were no thalamic lesions, but she had lesions in the bilateral caudate nuclei and putamen that were more prominent on the left side. ANE can rarely involve the cerebral white matter, internal capsule, basal ganglion, putamen, brainstem, and cerebellum. 3 
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The Neuroradiology Journal 30 (2) Influenza A (H1N1) is the most commonly associated virus of ANE. 2 Encephalitis caused by human HboV has also been reported, 4,5 although HboV has not been reported as causing ANE. Our patient had MRI findings consistent with those described in ANE, and no influenza A virus was isolated from the upper respiratory tract, while HboV was positive in the nasal specimen. The patient presented with findings of encephalitis following a viral upper respiratory tract infection. HboV was detected in a nasal specimen using a real-time PCR method. She had no pre-existing neurological or metabolic disease. No other cause of encephalopathy was found after a thorough investigation. For these reasons, we believe the ANE was related to HboV in our patient.
In summary, although ANE is often linked to influenza, it may develop secondarily to HboV, a recently identified respiratory tract pathogen.
